Founder

Riccardo was the founder of Okairos, an infectious disease genetic vaccine company. The genetic vaccine platform developed by Okairos, successfully tested in over four thousand individuals, [...]

Dr. Gallagher currently serves as President and Head, Research & Development at Syndax Pharmaceuticals. As a physician-scientist, trained gynecological oncologist, and research scientist [...]

Leading the Biotech team at Panakes Partners since 2021, Dr. Rob Woodman has global experience in biotech and pharma gained in both institutional and corporate venture firms, encompassing de novo [...]

Doug joined Revelation Partners in 2020.  With seventeen years of investment experience, Doug focuses on biopharma, diagnostics, and medical device investments.  Over his career Doug has invested [...]

Paolo is Managing Partner at XGEN Venture and is board member for TES Pharma, NanoPhoria and Genespire and board observer for Nouscom and iOnctura. Before co-founding XGEN in 2021, he was in [...]

Giovanni is Partner of the Biotech Fund at Indaco Venture Partners. He has more than 20 years of experience in drug discovery and development. Previously he led the biology unit of Intercept [...]

Paolo is the Chief Executive Officer and Managing Director of Angelini Ventures. He is currently a board member of Argobio and Extend, an observer board member of Pretzel Therapeutics, GenEp, and [...]